Fig. 1From: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s diseaseThe continuum of Alzheimer’s disease pathology from the preclinical and prodromal stages to overt clinical dementia plus the relative importance of biomarker assessment and functional assessment at the different stagesBack to article page